About
FDFO is a private family investment office established in 2000, following the exit of Cinemex — the cinema exhibition business co-founded by Adolfo Fastlicht. Twenty-five years later, we steward a multi-generational portfolio spanning real estate, hospitality, consumer, technology, healthcare, and financial infrastructure.
Every conviction starts with a person. We spend most of our diligence on the founder: do they think clearly? Have they been tested? Do they tell the truth when it costs them something?
Capital is plentiful. Time, attention, and trust are not. We deploy all three sparingly, on operators we genuinely believe in.
Most pools of capital have a clock. Ours doesn’t. No redemption pressure, no fundraising cycles, no quarterly marks.
This lets us hold through downturns, back founders we believe in through hard rounds, and let compounding do what it does best — work uninterrupted, for a very long time.
We don’t take board seats or seek press. We provide capital, introductions when asked, and patience. Companies grow on their own terms.
The best signal of our value is being invited to invest in the next round.
A family office, properly run, doesn’t have to explain itself to anyone. We use that freedom deliberately — backing unusual people pursuing important problems, often before consensus arrives.
If our thesis would be obvious to everyone in the room, we’re probably too late.
We are generalists by temperament. Over twenty-five years, conviction has clustered in a handful of areas where patient capital has a structural advantage.
Long-hold positions in markets we know intimately — particularly Mexico, the U.S., and southern Europe. Real estate as a generational asset class, not a transactional one.
Direct ownership and partnerships in branded and boutique hospitality, from Pacific-coast resorts to boutique European city hotels.
Operating businesses building category-defining consumer experiences — from luxury cinema to early childhood education.
Operating positions in telecom and industrial technology, alongside selective late-stage venture exposure to companies redefining their categories.
Public and private positions in healthcare delivery and clinical-stage biotechnology, with a focus on durable platforms and patient operators.
The plumbing of the modern capital stack — ownership ledgers, public-market access, and the rails that make private markets work.
A small number of conviction-led managers and real-asset partners whose worldview overlaps with ours.
Anchored in markets where the family has long-standing relationships and local knowledge — primarily Mexico and the United States, with select positions in Europe and Asia.
We are generalists by temperament. Over twenty-five years, conviction has clustered in a handful of areas where patient capital has a structural advantage.
i.
We don’t review unsolicited decks. Nearly every investment we’ve made came through someone we’ve known and worked with for years.
ii
If a category has reached the cover of a magazine, we’ve probably missed it. We’d rather be early or wait for the next cycle.
iii
We don’t take board seats, executive titles, or operational responsibilities. Founders run their companies.
iv
No press, no speaking engagements, no thought leadership. Our reputation is built one founder at a time.